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cortactin. Nonetheless, there is much
to learn about the acetylation and de-
acetylation of cortactin. Is acetylation
simply used to turn off cortactin’s actin
activity or does it play a role in cycles
of actin at sites of membrane remodel-
ing? The recruitment of HDAC6 to
cortical sites suggests at least that
cortactin deacetylation is locally
controlled. How is acetylation-deace-
tylation of cortactin regulated? The in-
volvement of the small GTPase Rac is
one possibility, but phosphorylation
may be another. Coupling between
phosphorylation and acetylation of
histones has been observed. Key to
the future understanding of cortactin
acetylation will be the identification of
the cortactin acetyltransferase. This
study (Zhang et al., 2007) and earlier
work on the tubulin acetyltransferase
(Maruta et al., 1986), suggest that
these cytosolic acetyltransferase(s)
may differ from those involved in
histone acetylation.
Another important implication of this
paper (Zhang et al., 2007) is that it
indicates that the role of HDAC6 in cell
migration is not limited to micro-
tubule acetylation-deacetylation. In-
stead, HDAC6, and probably SIRT2,
appear to regulate both the
microtubule and actin cytoskeletons.
Thus, studies using drugs which inhibit
HDAC6 will now need to account for
their affects on both cytoskeletal ele-
ments. It will be interesting to test
whether cortactin deacetylation is af-
fected by the HDAC6 inhibitor tubacin,
which has been suggested to be spe-
cific for tubulin deacetylation (Haggarty
et al., 2003).
The work of Zhang et al. (2007) has
added cortactin to the ever-growing
HDAC6-pack and it is very likely that
the number of HDAC6-regulated cyto-
plasmic proteins will continue to grow.
A recent proteomic survey of acety-
lated proteins identified over 180 new
lysine-acetylated proteins, including
actin itself (Kim et al., 2006). It will be
important to determine which of these
proteins are deacetylated by HDAC6
to better understand how this remark-
able enzyme regulates complex cellu-
lar processes such as cell migration.
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Brassinosteroid (BR) signaling requires the BIN2 kinase-promoted interaction of 14-3-3 proteins with
the transcriptional regulators BZR1 and BZR2, which are subsequently redistributed to the cyto-
plasm by BRs. In this issue of Developmental Cell, Gampala et al. show that this redistribution
may fine-tune BR responses and serve to crosstalk with other signaling pathways.14-3-3 proteins received their some-
what ineffable name from being in frac-
tion 14 of an ion-exchange column
and being in fraction 3.3 after starch
gel electrophoresis of brain extracts
(Moore and Perez, 1967), and they
have since been found in all eukary-
otes. 14-3-3s function as dimeric pro-
teins (Figure 1) in which each monomer
is capable of binding to common pep-162 Developmental Cell 13, August 2007tide motifs found in target proteins.
The target motifs can undergo serine
phosphorylation that subsequently
changes the affinity of the target pro-
teins for binding to 14-3-3s. 14-3-3s
themselves can also be phosphory-
lated by (for example) PKC isoforms,
and this prevents interaction with tar-
get proteins (Aitken, 2006). The physi-
ological functions of 14-3-3s are quiteª2007 Elsevier Inc.diverse and range from transcriptional
regulation through interaction with
transcription factors to activation of
membrane proteins such as ATPases,
and they are often implicated in protein
translocation between the cytosol and
the nucleus (Aitken, 2006). In Arabi-
dopsis at least 12 different 14-3-3 pro-
teins have been identified that appear
to have isoform-specific subcellular
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Previewslocalization that is believed to be
governed in part by their respec-
tive interaction partners. However,
there is little evidence that an indi-
vidual 14-3-3 protein has a higher
affinity for one particular target.
This probably results in a high level
of redundancy, which appears to
prevent a direct forward genetic
analysis of their function (Paul
et al., 2005). Recently, a number
of 14-3-3s have been found to be
associated with plant membrane
receptor kinases; in particular,
with members of the SERK and
the BRI1 family (Karlova et al.,
2006), which are receptors shown
to be involved in BR signaling.
However, the significance of this
association was not demonstrated.
In this issue of Developmental Cell,
Gampala et al. (2007) provide the first
evidence that 14-3-3s are indeed func-
tionally involved in the BR pathway
in Arabidopsis. Their approach has
employed an elegant strategy to over-
come the expected redundancy due
to the presence of many orthologous
family members, and has zeroed in
on the two transcriptional activators
that are identified as immediate tar-
gets of the brassinolide-activated and
BRI1-mediated pathway, BZR1 and
BZR2/BES1. Briefly, BRI1 activation
has previously been shown to result
in dephosphorylation of BZR1 and
BZR2 through the action of the nu-
clear-located phosphatase BSU1 and
the inhibition of the GSK3 kinase BIN2.
Inactivated phosphorylated BZR1 and
BZR2 proteins are translocated from
the nucleus into the cytoplasm (He
et al., 2005). Recently, this model was
refined to show that inactivation of
BZR1 and BZR2 by BIN2-mediated
phosphorylation directly, rather than
removal of the phosphorylated pro-
teins from the nucleus, was instrumen-
tal for their role in BR signaling (Vert
and Chory, 2006). In the present work
Gampala et al. show that 14-3-3 pro-
teins interact with the BIN2-phosphor-
ylated targets in the BZR1 protein,
while mutation of the BZR1 and BZR2
14-3-3 target sites results in constitu-
tive BR response phenotypes and lo-
calization in the nucleus similar to what
is seen in dominant bzr1 and bzr2 mu-
tants. Based on various protein inter-
action studies, it seems likely that the
14-3-3l isoform is the responsible iso-
form, but as expected, due to the re-
dundancy within the family, no effects
were found in knockout mutations in
this and other 14-3-3 genes.
The picture that emerges from these
recent studies suggests that BRs not
only directly regulate activity of the
BZR1 and BZR2 proteins, but also their
subcellular distribution. Apparently
that last aspect can be regulated inde-
pendently from DNA binding prop-
erties of the BZR proteins via the
interaction with 14-3-3 proteins. It is
clearly documented by Gampala et al.
(2007) that the introduced mutation in
the 14-3-3 binding site does not affect
any measurable aspect of BZR1 activ-
ity, including its DNA binding proper-
ties, other than its removal from the
cytoplasm into the nucleus. Through
the activity of 14-3-3 proteins, there ex-
ists the possibility of fine-tuning the
precise subcellular distribution of the
BZR proteins. Due to the role of 14-3-3
proteins in other pathways, such as
abscisic acid (ABA) signaling, they
may also be in part responsible for
crosstalk between various pathways.
In line with this idea is the observed
dependence of 14-3-3 interaction pro-
perties and protein localization on
developmental and environmental in-
puts. Even greater complexity can be
introduced in such a system when, for
instance, different members of the
14-3-3 family exert stimulatory and
inhibitory properties on their targets,
as it has been observed for the
nuclear mammalian glucocorticoid
receptors (Kim et al., 2005). It is
clear that the use of such con-
served signaling components such
as GSK3 kinases and 14-3-3 pro-
teins points to an ancient origin of
BR signaling. However, if also in
BR signaling, diverse effects are
regulated by different members of
the 14-3-3 family, the next im-
mediate question is how the pre-
cise regulation and association
with the right type of 14-3-3s is
achieved. So far, this problem has
not been addressed, but one hint
may be found in recent work of the
Oecking laboratory, where a pre-
cise stoichiometric state is shown
to occur between 14-3-3s and
ATPase monomers to achieve the hex-
americ active ATPase configuration
(Ottmann et al., 2007). One could en-
visage that multiple BR signaling com-
plexes incorporating either stimulatory
or inhibitory 14-3-3 members exist.
Viewed this way, one can propose
that 14-3-3s are a class of regulatory
proteins, perhaps ‘‘intelligent’’ scaf-
folds, that is active in various signaling
complexes and is already incorporated
at the stage where the entire signaling
complex is first assembled. It will now
be of great interest to see if other
14-3-3 proteins act as positive rather
than negative regulators in the BR sig-
naling pathway, and where and how
these are selected and incorporated
in different signaling complexes.
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Figure 1. Dimeric Structure of the Human
14-3-3eta Protein Complexed with Peptides
Fromhttp://structure.ncbi.nlm.nih.gov/Structure/mmdb/
mmdbsrv.cgi?Dopt=s&uid=36278 (Chen et al., 2003).Developmental Cell 13, August 2007 ª2007 Elsevier Inc. 163
Developmental Cell
PreviewsMoore, B.W., and Perez, V.J. (1967). Specific
acidic proteins of the nervous system. In Phys-
iological and Biochemical Aspects of Nervous
Integration, F.D. Carlson, ed. (Woods Hole,
MA: Prentice-Hall), pp. 343–359.The Nuclear Life
Bernike Kalverda1 and Maarten Forne
1 Department of Tumor Biology, Netherlands
*Correspondence: m.fornerod@nki.nl
DOI 10.1016/j.devcel.2007.07.008
Nucleoporins are the constituents
the nuclear interior, the function o
et al.’s mechanistic studies of le
that they have a direct role in tran
Nucleoporins are the molecular com-
ponents of the nuclear pore complex
(NPC), a structure that permits selec-
tive exchange between the nucleus
and cytoplasm of interphase eukary-
otic cells. The functional elements in
nucleoporins that permit the existence
of the selective passage appear to be
the nucleoporin phenyl-alanine-glycine
(FG) repeats, which form a barrier at
the center of the NPC. Surprisingly,
these FG regions are also encountered
in a large number of oncogenic fusion
proteins. The most promiscuous FG
repeat region is that of Nup98, which
is found in no less than 19 different on-
cogenic fusion proteins (Romana et al.,
2006). These fusions are generated as
consequences of chromosomal trans-
location or inversion that are associ-
ated with multiple types of myeloid or
lymphocytic leukemia. A second onco-
genic FG repeat is that of Nup214,
which is found in two different leuke-
mia-associated fusion proteins (von
Lindern et al., 1992). How do these
quintessential nucleoporin domains
function in leukemogenesis, and does
this reflect a regular function of nucleo-
porins? A recent article by Wang et al.
(2007) inNatureCell Biology clearly de-
fines the role of one of the oncogenic
Nup98 fusions, Nup98-NSD1. It also
adds importance to the question of
whether Nup98 has roles that are not
164 Developmental Cell 13, August 2007 ªOttmann, C., Marco, S., Jaspert, N.,
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Vandermeeren, C., Duby, G., Boutry, M.,
Wittinghofer, A., et al. (2007). Mol. Cell 9,
427–440.of Nucleoporins
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f which is unclear. In a recent iss
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scription.
directly related to nucleocytoplasmic
transport.
The largest group of Nup98 onco-
genic events fuses the Nup98 FG
repeat region to homeodomain tran-
scription factors, in particular those
of the HoxA, HoxC, HoxD, and Prrx
(Pmx) subfamilies. This results in chi-
meric transcription factors that are
able to transactivate or transrepress
target genes (Bai et al., 2006; Kasper
et al., 1999). Transactivation or trans-
repression coincides with the ability
of FG repeats to interact with CBP/
p300 acetyltransferase (Kasper et al.,
1999) or histone deacetylase HDAC1
(Bai et al., 2006), respectively. Interest-
ingly, in the case of Nup98-HoxA9, the
Nup98 FG region can be functionally
replaced by those of Nup153 and
Nup214, suggesting that recruitment
of CBP/p300, and perhaps other his-
tone modifiers, is an intrinsic property
of FG repeat regions.
Apart from homeobox transcription
factors, Nup98 is also found fused to
two related histone methyltransferases,
NSD1 and NSD3, as a consequence of
recurring chromosome translocations
in acute myeloid leukemia (for refer-
ences see Wang et al., 2007). Using
expression studies and chromatin im-
munoprecipitations, it was found that
Nup98-NSD1 directly activates HoxA10,
A9, and A7 gene transcription, which
2007 Elsevier Inc.Paul, A.L., Sehnke, P.C., and Ferl, R.J. (2005).
Mol. Biol. Cell 16, 1735–1743.
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hey are also known to shuttle to
ue of Nature Cell Biology, Wang
contain nucleoporins suggest
correlated with increased histone acet-
ylation and methylation (Wang et al.,
2007). Reversely, deletion of the methyl
transferase domain or CBP/p300
binding domain of Nup98-NSD1 ren-
dered the fusion protein transcription-
ally inactive. Nup98-NSD1-mediated
expression of the HoxA10-9-7 locus
was required for self-renewal of pri-
mary myeloid progenitor cells, which
clearly links the two histone modify-
ing activities of Nup98-NSD1 to tu-
morigenesis (Figure 1A). Interestingly,
HoxA9 is also a direct transcriptional
target of the Nup98-HoxA9 fusion
protein (Wang et al., 2006). Therefore,
Nup98-NSD1 and Nup98-HoxA9 may
function in a similar manner: through
recruitment of CBP/p300 via Nup98
FG repeats to the HoxA locus.
These data place the FG domain of
Nup98, and by extension those of
Nup153 and Nup214 (Kasper et al.,
1999), firmly in the context of tran-
scription. This raises the question of
whether any other direct links exist
between nucleoporins and transcrip-
tion. Indeed, in yeast, nucleoporins
have been found to bind to transcrip-
tionally active genes, and certain loci
are targeted to the nuclear periphery
upon activation (reviewed in Taddei,
2007). Therefore, it is possible that
the NPC recruits histone modifiers
through FG repeat regions, creating an
